Cough Suppressant Drugs Market Introduction

Cough is a reflex action that clears the throat of mucus or any sort of foreign irritants. Coughing is the most common symptom of a number of medical conditions. According to a study published in the Journal of the Association of Physicians of India, cough is the sixth most common reason for hospital outpatient department visit. Factors that increase the risk of dry cough include exposure to pollutants/environmental irritants, residence close to heavy traffic leading to respiratory problems, cigarette smoking, asthma, chronic obstructive airway disease, use of angiotensin converting enzyme, acute & chronic infections, airway diseases, parenchymal disease, cardiovascular, and gastrointestinal.

Based on type, cough can be divided into acute cough and chronic cough. Cough suppressants are also known as antitussives. Cough suppressants inhibit cough coordinating region in the brain stem. High prevalence of cough is projected to increase demand for cough suppressant drugs during the forecast period, which in turn is anticipated to drive the global cough suppressant drugs market.

Identify the key factors that will drive your company’s growth, Request a brochure of this report here

Cough Suppressant Drugs Market – Competitive Landscape

The global cough suppressant drugs market is highly fragmented with several domestic players holding key market share in respective region. The low cost of manufacturing, easy availability of these products, large volume business for cough suppressant drugs and easy entry for new players into cough suppressant drugs market. All these factors have attracted large number of domestic manufacturers into this field. Major players operating in the global cough suppressant drugs market focus on business expansion and are engaged in mergers and collaborations.

Perrigo Company plc

Perrigo Company plc is an Ireland-based company that generates 70% of its revenue from the U.S. and has significant presence in the global cough suppressant drugs market. The Company is a leading provider of over-the-counter health and wellness solutions.

Pfizer, Inc

Pfizer, Inc. is another multinational company with strong presence in the cough suppressant drugs market in North America. Pfizer Inc. is a global pharmaceutical company that develops, manufactures, and markets prescription medicines in 11 therapeutic segments, including cardiovascular, oncology, neuroscience, pain, and infectious diseases. It operates through two business units: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).


GlaxoSmithKline is a global pharmaceutical company actively involved in research, development and manufacturing innovative pharmaceutical medicines, vaccines and consumer healthcare products. In 2018, GlaxoSmithKline invested around 4.60 Mn USD for research and development of pipeline products.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals worldwide. The company delivers high-quality and patient-centric health care solutions across the globe. It has a wide generic product portfolio with more than 35,000 products in almost every therapeutic area.The company primarily operates through two business segments : Generic medicines and specialty medicines.Teva Pharmaceutical Industries Ltd. markets its gout therapeutic drug under its generic medicines business segment

Other players operating in the global cough suppressant drugs market include Tris Pharma, Inc., Aytu BioScience, Inc., Mayne Pharma Group Limited, and Acella Pharmaceuticals, LLC.

Expanding operations in future? To get the perfect launch ask for a custom report here

Cough Suppressant Drugs Market – Dynamics

Anticipated launch and commercialization will drive the cough suppressant drugs market.

A large number of drug candidates are in different stages of clinical trial approval in the U.S. and Europe. The anticipated launch and commercialization of these products is expected to propel the global cough suppressant drugs market during the forecast period.

The cough suppressant drugs market to grow with high prevalence of cough.

According to the Journal of the Association of Physicians of India data, around 54% of population of India suffered from Cough. The global cough suppressant drugs market is projected to expand at a rapid pace during the forecast period. Increase in the geriatric population, changes in lifestyle, and rise in health care awareness are the major factors driving the global market.

Favorable health care policies lead to an increase in affordability of various health care treatments. This, in turn, increases the life expectancy of the population. The population aged above 65 years usually suffers from various health disorders. Hence, increase in the geriatric population augments the global cough suppressant drugs market. However, stringent government regulations for sale of over-the-counter cough suppressant drugs are likely to restrain the global cough suppressant drugs market.

Cough Suppressant Drugs Market – Segmentation

On the basis of drug type, the global market can be divided into

  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butramirate
  • Bennzonatate
  • Pholcodine

On the basis of dosage form, the global market can be divided into

  • Syrup
  • Tablet

On the basis of distribution channel, the global market can be divided into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others (specialty clinics)

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Cough Suppressant Drugs Market

Pre Book